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ABSTRACT 
 
Membranes are barriers that assure the selective communication of the internal 
media with the external environment, a process that is crucial for life. Membrane 
components, lipids and proteins, are the main players responsible for the membrane 
selective permeability and its regulation. The work presented in this thesis encompasses 
different aspects of biological membranes features.  
 
The first part of this thesis is dedicated to the study of the influence of dietary 
lipids in membrane biophysical properties, namely fluidity and permeability. We used 
animal models and designed experiments where the effect of the diet supplementation 
with fatty acids, PUFA and the conjugated linoleic acid (CLA) on membrane composition, 
fluidity and permeability, were analysed. In addition, since the animal genetic background 
is known to have an important contribution to the regulation of several biochemical 
pathways and resulting in different phenotypes, this variable was included in the study.  
 
Within the same animal species all adipose membranes were found richer in SFA 
independently of their genetic background or diet. The lipid adipose membrane 
composition of Zucker rats is highly dependent on the lipid composition of the diet. 
Regarding the adipose membrane biophysical properties, we were able to correlate a 
decrease in membrane fluidity and the concomitant decrease on permeability to water 
and glycerol with the incorporation of t10,c12 CLA isomer into adipose membranes of 
Zucker rats. Interestingly, this CLA isomer is the one with suggested fat lowering 
properties in several animal studies. The animal genetic background in obese pigs was 
also found to play a determinant role on the fluidity of adipose membranes, in 
accordance with the reported for a wide variety of cell membranes from obese mice and 
rats. Interestingly, the same increase in membrane fluidity was observed for pigs fed a 
low protein diet and was correlated with the ratio oleic /linoleic acid. A similar effect was 
consistently reported in adipose membranes of genetically obese mice pointing to a clear 
compensatory mechanism to maintain membrane biophysical properties. 
 
The second part of this thesis is dedicated to the study of membrane protein 
channels, aquaporins, aiming at identifying new modulators with potential 
pharmacological use. Furthermore, building an experimental cell model able to 
characterize individual aquaporin activity and selectivity as well as to validate modulators’ 
effect and potency was another goal of this work. 
 
Using the human erythrocyte that expresses one orthodox aquaporin (AQP1) and 
one aquaglyceroporin (AQP3), we reported on the potent and selective inhibition of 
human AQP3 by a water-soluble gold(III) coordination compound, Auphen. 
 
From molecular modelling studies and docking approaches, we were able to 
propose a mechanism of action of Auphen for human AQP3 inhibition, where Cys40 is 
the crucial residue for binding. Inhibitory assays with other metal complexes, namely 
phenantroline derivatives of Pt(II) and Cu(II), showed that the AQP3 inhibition potency 
decreased drastically in the order Au(III) > Cu(II) >> Pt(II). Interestingly, no inhibition effect 
was achieved when incubating the cells with gold(I) compounds, therefore, 
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demonstrating the necessity of gold(III)-based scaffolds to achieve protein binding and 
blockage of the channel. Our mechanistic hypothesis was based on the possibility for 
Auphen and analogues to bind to certain amino acid residues in the channel close to the 
selectivity filter domains, thus acting as a “cork” preventing the passage of glycerol. 
 
Given the diversity of pathologies associated with dysfunction of the different 
aquaporins, these proteins are now emergent drug targets. However, cells and tissues 
frequently express more than one aquaporin isoform in the plasma membrane and unless 
a specific isoform is mutated or overexpressed, its function is not easily discriminated. To 
overcome this difficulty, we developed a yeast heterologous system for expression and 
functional assessment of aquaporin isoforms. Such a cell system expressing individual 
AQPs would also be very useful for analysis of function and regulation of aquaporins from 
the plant kingdom. Plants express numerous aquaporin isoforms, but for most their 
physiological relevance is still unclear. 
 
Using this approach, grapevine aquaporins VvPIPs, VvTIPs and VvSIPs were 
expressed in yeast and functionally analysed. We demonstrated that only some isoforms 
are functional while others are not, and they may transport other small molecules of 
physiological importance such as ammonia, boron, CO2, hydrogen peroxide and urea. In 
particular for VvSIP1, we disclosed for the first time its ability to transport water but not 
glycerol, urea, sorbitol, glucose, or inositol. 
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SUMÁRIO 
 
As membranas biológicas comportam-se como barreiras que asseguram a 
comunicação seletiva do meio interno com o ambiente externo, um processo que é 
crucial à vida. Os componentes membranares, lípidos e proteínas, são os principais 
responsáveis pela permeabilidade seletiva das membranas e sua regulação. O estudo 
apresentado nesta tese abrange diferentes aspetos característicos das membranas 
biológicas. 
 
A primeira parte desta tese foi dedicada ao estudo da influência dos lípidos da 
dieta nas propriedades biofísicas das membranas, em particular fluidez e permeabilidade. 
Foram utilizados modelos animais e concebidos ensaios experimentais onde se analisou 
o efeito da suplementação da dieta em ácidos gordos, PUFA e ácido linoleico conjugado 
CLA, na composição lipídica, fluidez e permeabilidade das membranas do tecido adiposo. 
Ainda, uma vez que a herança genética tem uma contribuição importante para a 
regulação de vários processos metabólicos resultando em fenótipos diversos, esta 
variável também foi incluída neste estudo. 
 
Na mesma espécie animal, as membranas de tecido adiposo são mais ricas em 
ácidos gordos saturados independentemente da sua raça ou dieta. A composição lipídica 
das membranas de tecido adiposo de ratos Zucker é muito dependente da composição 
lipídica da dieta. Relativamente às propriedades biofísicas, foi possível correlacionar um 
decréscimo da fluidez da membrana e concomitante decréscimo da permeabilidade à 
água e ao glicerol com a incorporação do isómero de CLA t10,c12 nas membranas do 
tecido adiposo de ratos Zucker. Curiosamente, em diversos estudos animais têm sido 
atribuídas propriedades de emagrecimento a este isómero CLA. 
 
A herança genética (raça) também tem um papel importante na fluidez das 
membranas do tecido adiposo, em concordância com o já descrito em vários estudos em 
membranas celulares de ratinhos e ratos obesos. Também se verificou um aumento da 
fluidez membranar em porcos alimentados com restrição proteica, o que foi 
correlacionado com a razão dos ácidos oleico/ linoleico. Um efeito semelhante foi já 
reportado para membranas de tecido adiposo de ratinhos geneticamente obesos, 
apontando para um mecanismo compensatório que leva à manutenção das propriedades 
biofísicas das membranas. 
 
A segunda parte desta tese foi dedicada ao estudo de canais proteicos 
membranares, as aquaporinas, com o objetivo de identificar novos moduladores com 
potencial utilização farmacológica. Ainda, pretendemos desenvolver um modelo 
experimental para a caracterização individual da atividade e seletividade de aquaporinas 
e para a validação do efeito e da potência de moduladores. 
 
Utilizando eritrócitos humanos que expressam uma aquaporina ortodoxa (AQP1) 
e uma aquagliceroporina (AQP3), descrevemos a forte inibição seletiva da AQP3 por um 
composto de coordenação de ouro(III) hidrossolúvel, o Auphen. 
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Através de estudos de modelação molecular e de docking, foi possível propor um 
mecanismo de ação do Auphen para a inibição da AQP3 onde o resíduo de cisteína cys40 
é crucial para a ligação. 
 
Os ensaios de inibição com outros complexos metálicos, nomeadamente 
derivados da fenantrolina de Pt(II) e de Cu(II), revelaram que a inibição decresce 
drasticamente na ordem Au(III)  Cu(II) >> Pt(II). Curiosamente, não se observou inibição 
quando as células foram incubadas com compostos de gold(I), demonstrando assim a 
importância dos esqueletos dos compostos de gold(III) para a ligação à proteína e 
bloqueio do canal. Assim, a nossa hipótese de mecanismo é baseada na possibilidade do 
Auphen e análogos se ligarem a certos resíduos de aminoácidos no canal, perto do filtro 
de seletividade, atuando deste modo “como uma rolha” que impede a passagem do 
glicerol. 
 
Devido á diversidade de patologias relacionadas com a disfunção de diferentes 
aquaporinas, estas proteínas são atualmente consideradas alvos terapêuticos. Contudo, 
na membrana plasmática das células e tecidos é frequentemente expressa mais do que 
uma isoforma de aquaporina, pelo que a sua função não é facilmente discriminada a não 
ser que essa isoforma específica seja mutada ou sobre-expressa. Para ultrapassar esta 
dificuldade, foi desenvolvido um sistema de expressão heteróloga em leveduras para a 
expressão e análise funcional de aquaporinas. Tal sistema também é muito útil para a 
análise da função e regulação de aquaporinas do reino vegetal. As plantas expressam 
numerosas isoformas de aquaporinas mas na maior parte dos casos, a sua relevância 
fisiológica ainda não foi estabelecida. 
 
Utilizando esta abordagem, as aquaporinas de uva VvPIPs, VvTIPs e VvSIPs foram 
expressas em leveduras e a sua função foi analisada. Foi demonstrado que somente 
algumas isoformas são funcionais, e que algumas podem estar envolvidas no transporte 
de outras moléculas com importância fisiológica tais como amónia, boro, CO2, peróxido 
de hidrogénio e ureia. Em particular para a VvSIP1, foi pela primeira vez revelada a sua 
capacidade para transportar água mas não glicerol, ureia, sorbitol, glucose ou inositol. 
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GENERAL AIMS AND THESIS OUTLINE 
 
The plasma membrane is the boundary of the cell, separating its content from the 
environment. This semipermeable membrane is composed of a lipid-bilayer where 
thousands of different lipid molecules interact dynamically, forming transient or stable 
structures used by many proteins as platforms for their activity and to enhance their 
interactions with other proteins. One fundamental cell membrane function is to quickly 
respond to intra and extracellular events, accomplishing transmembrane fluxes 
fundamental to the physiology of all living organisms. 
 
Water is the major component of all living organisms. The controlled flow of water 
through biological membranes not only plays a key role in cellular homeostasis but also 
contributes to cell survival. Triggered by osmotic and/or pressure gradients, water 
crosses the membrane both through the lipid-bilayer and specialized membrane 
channels called aquaporins (AQP), which facilitate highly selective and efficient flow of 
water and, in some cases, other small solutes such as glycerol and urea. 
 
This work is focused in the study of membrane characteristics that affect the 
permeability of water or small uncharged solutes such as glycerol. Within this scope, 
membrane biophysical properties modulated by lipid membrane composition and by the 
activity of aquaporin channels play a central role. 
 
This work is divided in two parts, Part I (containing chapter 1) and Part II 
(containing chapter 2 and 3). 
 
The first part is dedicated to study the influence of genetic background and diet 
composition on adipocyte membrane composition and its outcome on membrane 
biophysical properties such as fluidity and permeability to water and glycerol. 
It is known that dietary fatty acids incorporate into cell membrane phospholipids. 
The health beneficial effects attributed to dietary compounds such as polyunsaturated 
fatty acids (PUFA) are vast. Examples are their protective effects on hypertension, 
cardiovascular diseases, and cancer, among others 1. Albeit several candidate 
mechanisms have been suggested, the means by which they elicit their effects remain 
largely unknown. In view of the broad range of effects attributed to these compounds, it 
is expected that, at least in part, they act at some fundamental cellular level common to 
all organism. 
Our previous results 2 have shown that kidney plasma membranes from Wistar 
rats, fed with palm oil-based diets supplemented with conjugated linoleic acid 
(considered a fat lowering fatty acid ), showed altered membrane permeability, an effect 
that was correlated with the incorporation of this fatty acid into the plasma membrane. 
With this starting point, this work aims at further understanding the effects of fatty acids 
and food components on cell membranes and their outcome on membrane composition 
and biophysical properties such as permeability and fluidity. 
In chapter 1 we present 3 publications where we studied the influence of dietary 
lipids, protein restriction conditions and genetic background on adipocyte membrane 
composition and its outcome on membrane biophysical properties such as fluidity and 
permeability to water and glycerol (publications 1, 2 and 3). 
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The second part is divided in two chapters (chapters 2 and 3) in which human and 
plant aquaporins were studied. 
AQPs are a family of small transmembrane proteins ubiquitous in nature. These 
proteins form highly selective channels for water and, in the case of the sub-family 
aquaglyceroporins, other small solutes such as glycerol and urea. 
 
In chapter 2, human aquaporins were investigated regarding the screening for 
specific inhibitors. 
 Thirteen different mammalian AQPs have been identified so far, present in 
almost all organs and tissues. It is clear that they play fundamental roles in human 
physiology and pathophysiology, their dysfunction or aberrant expression is correlated 
with several diseases such as kidney diseases, brain oedema, obesity and cancer3. 
Numerous reports have highlighted the possible areas where AQP modulators could be 
useful in treating human diseases. Yet, only a few pharmaceutically relevant compounds 
have been identified to date and none of them proved to be suitable for clinical trials. 
Using a screening system based on permeability assays of human red blood cells 
(RBC), we investigated modulators of aquaporin activity (publications 4 and 5). 
 
In chapter 3, the activity of different isoforms of plant aquaporins natively located 
in plasma membrane and in intracellular membranes of grapevine, was characterized. To 
assess their individual activity and contribution to membrane permeability, we used a 
yeast heterologous expression model that was optimized for the expression and 
functional analysis of aquaporins and is now suitable to be used as inhibitor screening 
system (publications 6 and 7). 
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INTRODUCTION 
 
The plasma membrane represents the barrier of life, the structure that separates 
the cells from their surroundings. This semipermeable membrane is composed of a lipid-
bilayer embedded with proteins accomplishing fundamental processes central to the 
physiology of the cell. In this context, the lipid composition of the cell membrane and the 
transporters within, play a central role. Part I will deal with the bilayer composition of the 
membrane and its biophysical properties. 
 
 
The Lipid-Bilayer 
 
This part of the work aimed at studying plasma membrane lipid composition and 
its outcome in biophysical properties such as fluidity and permeability to water and 
different solutes in response to different dietary compositions, namely, fatty acids (FA) 
content and protein restriction.  
 
 
1. Composition and properties of the lipid-bilayer. 
 
Biological membranes have a similar general organisation in sheet-like structures, 
composed of a heterogeneous and asymmetric lipid-bilayer firmly established as the 
universal basis for cell-membrane function. Herein, thousands of different lipid molecules 
interact dynamically, forming transient or stable structures used by many proteins as 
platforms for their activity and to enhance their interactions with other proteins4,5. 
 
Membrane lipids are divided in three classes of amphipathic lipids: phospholipids, 
glycolipids, and sterols. The amount of each amphipathic lipid depends upon the type of 
cell, but in the majority of cases phospholipids are the most abundant, while glycolipids 
are found exclusively in the outer layer of the membrane. Cholesterol is also abundant in 
eukaryotic cell membranes - up to one molecule for every phospholipid molecule. 
Phospholipids and glycolipids share a similar structure containing a hydrophilic 
headgroup and one or two hydrophobic tails. Phospholipids are derived from either 
glycerol (phosphorglycerides) or sphingosine (sphingolipid), having the following 
components: a glycerol or sphingosine backbone, two or one FA chains, a phosphate 
group and (usually) an alcohol (e.g. choline, ethanolamine, inositol) (Figure 1). The FA tails 
can differ in length (containing normally between 14 and 24 carbon atoms) and may be 
saturated or unsaturated. The number of double bonds present in their hydrocarbon 
chains can vary from none, saturated fatty acid (SFA), one, monounsaturated fatty acid 
(MUFA) to several, polyunsaturated fatty acid (PUFA). 
 
Each double bond creates a small bend in the tail. Differences in the length and 
saturation degree of the FA tails influence their ability to pack against one another, 
thereby affecting the fluidity and other biophysical properties of the membrane6. 
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Figure 1 – Schematic drawing of common membrane lipids. 
 
The variety of headgroups and aliphatic chains allows the existence of more than 
1000 different lipid species in any eukaryotic cell7. This diversity is only beginning to be 
characterized while lipidomics is becoming an important tool in cell and developmental 
biology, molecular medicine and nutrition8. The membrane composition differs 
throughout inner and outer sheets of lipid bilayer, cell organelles and cell type7 The 
assortment of lipid species allows to adapt the lipid composition of membranes to fulfil 
specific functions. How the organism regulates lipid composition and the exact 
mechanisms of how compositional complexity affects cell homeostasis and its regulation 
remains poorly understood8. 
The effect of lipid composition on biological membranes points to an extensive 
list of perturbations induced on membrane lipid structure including changes in 
membrane fluidity, phase behaviour, permeability, membrane fusion, lateral pressure 
and flip-flop dynamics7,5. In this manner FAs influence the membrane function at several 
levels including membrane microdomain organization, membrane proteins activity, cell 
signalling and ultimately human health5. 
 
 
1.1. The fluidity of a lipid-bilayer depends on lipid composition. 
 
Three main factors, besides temperature and the head group of membrane lipids, 
contribute to membrane fluidity: membrane lipid tail length, the degree of unsaturation 
of lipid tails and the amount of cholesterol. 
The tail length affects fluidity as lipids with longer tails exhibit more friction when 
moving around in the membrane. In other words, the longer the tails, the higher the 
attractive van der Waals forces between them. As a result, membranes with longer lipid 
tails tend to be less fluid. 
The average degree of unsaturation of lipid tails also affects membrane fluidity, 
as unsaturated tails do not pack as tight as saturated ones, therefore increasing 
membrane fluidity. 
Cholesterol molecules contribute to membrane fluidity enhancing the 
permeability-barrier properties of the lipid bilayer. They orient themselves in the bilayer 
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with their hydroxyl group close to the polar head groups of the phospholipid molecules. 
In this position, their rigid, plate-like steroid rings interact with, and partly immobilize, 
those regions of the hydrocarbon chains closest to the polar head groups (Figure 2). By 
decreasing the mobility of the first few CH2 groups of the hydrocarbon chains of the 
phospholipid molecules, cholesterol makes the bilayer less deformable in this region and 
thereby decreases its permeability. Although cholesterol tends to make lipid bilayers less 
fluid, at the high concentrations found in most eukaryotic plasma membranes it also 
prevents the hydrocarbon chains from coming together and crystallizing. In this way, it 
inhibits possible phase transitions6. 
 
 
 
Figure 2 - Schematic drawing of a cholesterol molecule interacting with two phospholipid molecules. 
 
Cholesterol and length and unsaturation degree of fatty acyl chains are not the 
only players regarding membrane fluidity. The head group of phospholipids also 
influences membrane behaviour. For example, choline is a bulky headgroup causing 
phosphatidylcholine (PC) to have a cylindrical molecular geometry. In contrast, 
ethanolamine is a smaller headgroup, with phosphatidylethanolamine (PE) assuming a 
conical molecular geometry, allowing a tighter packing of the phospholipids. Thus, when 
the PE/PC ratio increases there is a reduction in membrane fluidity7. 
 
 
1.2. Effect of fatty acids on membrane permeability, membrane proteins activity and on 
micro-domain organization. 
 
FAs can influence membrane permeability, an effect that has been associated 
with disorder in the membranes' interior and the interaction of the incorporated lipid 
with the polar head group of phospholipids9. It is known that at the gel-to-fluid phase 
transition of 1,2-dimiristoyl-sn-3-phosphocholine (DMPC) bilayers, when the largest 
number of defects in the lipid matrix appears, membrane permeability reaches its 
maximum10. It has also been demonstrated that the dietary FA, docosahexaenoic acid 
(DHA) increases permeability more effectively than its metabolic precursor, linoleic acid 
(LA) or oleic acid (OA)11. DHA is incorporated into lipid membranes either as a FFA or as 
part of a phospholipid and can increase the permeability of phospholipid vesicles and 
tumour cells12. 
 
Since integral membrane proteins are surrounded by lipids, they are affected by 
this adjacent environment. Effects of lipid structure on membrane protein function can 
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be described either in terms of molecular interactions or in terms of physical properties 
of the lipid bilayer such as lipid fluidity, membrane tension, etc13. For example, it was 
proposed that FAs perturb the lipid bilayer and disturb the protein-lipid complementarity 
of the human erythrocyte membrane14, inducing changes in the morphology of the 
membrane and its fluidity, leading to changes in the activity of the human erythrocyte 
membrane sodium pump15,16. It has also been shown that sphingomyelinase activity in 
red blood cells is modified by membrane bending (surface tension)17, which in turn, is 
intimately linked with its shape. Curvature-sensing lipids and proteins localize to curved 
regions where they accumulate introducing a local curvature18. 
 
Biological membranes are heterogeneous structures organized in domains and 
microdomains, characterised by different lipid composition. Proteins may alter the lipid 
organization via protein-lipid interactions influencing the relative distribution of lipids and 
proteins in the membrane18. It’s likely that lipid microdomains form, at least in part, as a 
consequence of the distinct affinities between lipids5. One particular type of lipid domain 
is the lipid raft. Rafts are sphingolipid- and cholesterol-enriched liquid-ordered domains 
floating in “a sea” of liquid-disordered phospholipids19,20. Building on a wide variety of 
biophysical studies, it was proposed that a dietary FA with important effects in human 
health, DHA, is incorporated in membrane phospholipids affecting the organization of 
plasma membranes, inducing changes in raft and non-raft domains21,22. DHA is the 
longest, most unsaturated FA representing an extreme example of dynamical shape, 
rapidly interchanging between multiple configurations. The high degree of disorder 
introduced by DHA severely impacts lipid packing and hence membrane physical 
properties. Moreover, results obtained with model membranes show that DHA and 
cholesterol push each other away, leading to segregation of DHA containing 
phospholipids in highly disordered membrane domains23,24. These domains are 
compositionally and organizationally opposite to lipid rafts that are ordered domains 
predominantly enriched in sphingolipids "glued" by cholesterol. It was hypothesized that 
DHA-rich domains formed in the plasma membrane are responsible, at least in part, for 
the diverse range of health benefits associated with DHA by altering cellular biochemical 
activity, including essential signalling pathways21,22. 
 
 
1.3. Regulation of membrane lipid composition. 
 
The incorporation of FFA within membranes may occur quite rapidly. They can be 
detected either as free entities interlaid between the membrane lipids or as part of the 
membrane phospholipids after undergoing esterification. For example, OA molecules can 
be detected embedded within the phospholipids of membrane vesicles under 3 
minutes25,26. Concerning the esterification of FFA, some examples inculde, LA added to 
culture media is processed through the endoplasmic reticulum and appears in the plasma 
membranes phospholipids of neuroblastoma cells between 2–10 min after addition27. 
Another example is eicosapentaenoic acid (EPA) that may be detected as part of 
phospholipids and triacylglycerols in rat liver, brain and heart within 5 min after 
intravenous infusion28. Moreover, the synthetic FFA, 2-hydroxyoleic acid, has also been 
detected in phospholipids from U118 human glioma cells 2–24 h after incubation with 
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this lipid, causing a marked remodelling on the cell membrane FA composition. These 
changes lead to an important modulation of the cell membrane microdomain structure29. 
As referred above, insertion of FA into membranes and their incorporation in 
more complex molecules enable these acyl chains to induce changes in the structure of 
lipid bilayers with the concomitant change in their biophysical properties. Yet, regulation 
of membrane lipids composition with an appropriate balance between SFA, MUFA, and 
PUFA phospholipids acyl chains is critical for membrane organization and to maintain 
membrane biophysical properties tuned to optimize cellular function. That composition 
is regulated by complex mechanisms involving several transcription factors, such as sterol 
regulatory element binding proteins, whose activity is in turn modulated by sensitive 
sensory systems in response to changes in lipid levels30–32. 
 
 
2. Dietary fatty acids. 
 
The presence of FAs In human diet is essential for healthy growth and organism 
homeostasis inasmuch as FAs have important functions in energetic metabolism, signal 
transduction, molecular recognition processes and phospholipid membrane formation7. 
Intake of suitable dietary raw materials is a requirement for endogenous synthesis of 
appropriate lipids, which in turn is critical for the formation of membrane bilayers. 
After ingestion and until the incorporation of new lipids into the membranes, FAs 
face a complex set of processes involving digestion, absorption, transport, storage and 
metabolizing. During these processes FAs ingested in the diet are subjected to several 
alterations according to the body necessities. In the body, FAs derived from the diet and 
from de novo lipogenesis can be further elongated (via elongases) and unsaturated (via 
desaturases), generating a variety of lipid species that can then provide a specific lipid 
composition30. This variety of lipids is illustrated by the fact that cells use approximately 
5% of their genes to synthesize all of these lipids7. Thus, dietary FAs may influence 
membrane composition, although due to this complex set of processes together with 
membrane composition regulatory mechanisms, substantial changes in diet are often 
required for relatively small changes in membrane composition33. 
 
As some FAs (essential FAs) cannot be endogenously synthesized they have to be 
provided in diet rendering them important dietary components. 
 
 
2.1. Essential fatty acids. 
 
The n-3 and n-6 (or omega-3 and 6) FAs are a family of naturally occurring PUFAs 
(Figure 3). Since n-6 and n-3 double bonds cannot be inserted into FAs by animal enzymes 
allowing their endogenous de novo synthesis, the simplest members of n-6 and n-3 series, 
linoleic (18:2n-6) and α-linolenic (18:3n-3) FAs, are considered essential34. Symptoms of 
essential FA deficiency, similar to other essential nutrient deficiencies, have been 
reported in mammals35. 
In the cell, linoleic and α-linolenic acids are converted to longer chain FAs upon 
desaturation and elongation giving rise to the n-3 and n-6 series34(Figure 3). 
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Figure 3 – Metabolic pathways of essential linoleic (18:2n-6) and α-linolenic (18:3n-3) fatty acids. Different 
n- 3 and n-6 fatty acids are produced through elongation and desaturation of the essential linoleic and α-
linolenic acids, respectively. The addition of double bonds and the elongation of the acyl chains occur in 
the endoplasmic reticulum, while the final step in the synthesis of the n-3 DHA and the n-6 
docosopentaenoic acid consists of a single reaction from β-oxidation in the peroxisome. Carbon backbones 
of linoleic and α-linolenic acids are depicted. Carbons are numbered (in blue) from the first methyl group. 
Names include: number of carbons : number of double bonds n-carbon number of the terminal double bond (i.e. that closest to 
the methyl end of the hydrocarbon chain).  
 
The PUFAs of the n-3 and n-6 series play a significant role in health and disease. 
Both series are involved in the synthesis of potent modulatory molecules important for 
inflammatory responses, including eicosanoids (prostaglandins and leukotrienes) and 
cytokines (interleukins), affecting the gene expression of various bioactive molecules36,37. 
In general, the n-6 eicosanoids are considered pro-inflammatory while n-3 are much less 
so. The n-6 eicosanoids family of inflammatory mediators is generated from 20 carbon 
PUFA as the arachidonic acid (20:4n-6), liberated from cell membrane phospholipids37. 
Increased consumption of the long chain n-3 PUFA, such as the EPA (20:5n-3) and DHA 
(22:6n-3) acids, decreases the amount of arachidonic acid in cell membranes diminishing 
arachidonic acid-derived eicosanoids38. 
 
Since n-6 and n-3 PUFAs cannot be synthesised de novo, their availability to the 
composition of cell membranes is ultimately determined by the fraction present in the 
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diet. Actually, membrane composition was found to be more responsive to n-6 and n-3 
PUFA levels in the diet and most sensitive to n-3 PUFA and to the n-3/n-6 ratio33,39. 
 
 
2.2. Effect of dietary fatty acids in human health. 
 
A link between diet and disease is being increasingly recognized. Among dietary 
components, FAs have especially gained recognition in affecting health. The amount and 
type of FAs consumed are directly involved in the etiology of various diseases. While the 
ingestion of excessive amounts of SFAs and trans-fatty acids is considered to be a risk 
factor for cardiovascular diseases, insulin resistance, dyslipidemia, and obesity1, MUFAs 
and PUFAs are recommended, for example, for their cardio-protective benefits40. In 
particular, essential FAs from n-6 and n-3 series and their derivatives have varied 
biological actions and seem to be involved in several physiological and pathological 
processes such as obesity, hypertension, diabetes mellitus, coronary heart disease, 
schizophrenia, Alzheimer's disease, atherosclerosis, and cancer41. For example, 
numerous studies have shown that high olive oil intake reduces blood pressure; it was 
proposed that this effect would be caused by its high OA content, increasing OA levels in 
membranes and thus regulating membrane lipid structure in such a way as to influence 
the localization and/or activity of signalling proteins involved in hypertension42,43. DHA 
and EPA have also been associated with the prevention of cardiovascular diseases and 
cancer44. Gamma linolenic acid (GLA) (18:3n-6), a n-6 PUFA, has been suggested for 
potential applications as an anti-inflammatory nutrient or adjuvant36. 
Understanding the mechanisms by which FAs exert their biological effects is 
important in unravelling the pathogenesis of many disorders, ultimately providing 
effective preventive measures. Given the large number of processes and health benefits 
where FAs seem to be involved, it is reasonable to think that they may act at some 
fundamental level common to the whole organism. Their implications on membrane 
structure, may explain, at least partially, the modulation exerted by some natural FAs on 
cell function. In fact there is some evidence that a few metabolic pathologies are related 
to altered lipid composition. For instance, alterations in the FA composition of membrane 
phospholipids of human erythrocyte membranes have been linked to obesity and insulin 
resistance45. Another study in rats fed with a diet rich in SFA suggested that intake of the 
beef tallow diet promotes body fat accumulation by reducing lipolytic activities resulting 
from lower β-receptor binding and sympathetic activity in adipose tissues. The decreases 
in β-receptor binding affinities were correlated to changes in membrane fluidity46. 
 
 
2.3. Conjugated linoleic acid. 
 
Another interesting group of FAs is that formed by the conjugated linoleic acid 
(CLA). This is a family of 28 naturally occurring isomers of linoleic acid, with 18 carbons 
and 2 double bonds either on trans or cis configuration. CLA is produced by bio-
hydrogenation in ruminants or by bacteria from the gastro-intestinal tract of humans. 
Although as minor component, consumption of ruminant meat (beef and lamb) and dairy 
products (milk and cheese) is the main source of dietary CLAs47. Where the predominant 
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isomer formed is cis-9,trans11 (c9,t11) and unlike other trans double bond-containing 
FAs, it may have beneficial effects on human health48. 
Dietary supplements of CLA have been attracting consumers’ interest because of 
the alleged body fat-lowering effects, together with the perception of a natural 
compound devoid of harmful effects. These preparations present CLA mostly as a mixture 
of (c9,t11) and trans-10,cis-12 (t10,c12) isomers (Figure 4). 
 
 
 
Figure 4 - Structures of linoleic acid, and CLA isomers (c9,t11) and (t10, c12) 
 
There are several indications that various isoforms might have different biological 
actions. The c9,t11-isomer was implicated as the active form responsible for the 
protective effects against tumorigenesis. The t10,c12-isomer seems to be the active form 
that affects energy metabolism and body fat deposition and composition49. Despite 
numerous studies on CLA their true effect and the mechanism of action in such processes 
remain unclear49,50,51,52. 
 
It was reported CLA incorporation into membrane phospholipids of pigs fed with 
a commercial CLA mixture, where the distribution of CLA isomers in liver phospholipids 
showed an increase compared to that present in the diet53. 
 
 
3. Reduced protein diets (RDP). 
 
An equilibrated diet contains 10-15% of the total daily energy provided from 
protein. Reducing the proportion of protein relative to energy in the diet is known to 
increase fat deposition. Using pigs as animals models it was shown that plasma 
cholesterol increased dramatically in lean pigs fed low protein diets54 and that reduced 
dietary energy and protein in growing pigs significantly increased intramuscular fat55, 
while having a minor effect on the amount of subcutaneous adipose tissue56,57. One 
possible explanation for this effect is that the low protein content restricted muscle 
growth, resulting in excess energy being converted into intramuscular lipids rather than 
in endogenous protein synthesis56.  
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Since RDP affects FAs deposition in the body it would be interesting to investigate 
the effect of RDP on membrane composition and biophysical properties. 
 
 
4. Adipose tissue and obesity. 
 
Adipose tissue is a complex organ that regulates and coordinates energy 
homeostasis. This heterogeneous tissue is primarily composed of adipocytes surrounded 
by fibroblasts, fibroblastic preadipocytic cells, endothelial cells, nerves and immune cells. 
Although adipose tissue was originally thought to just be an energy storage site, studies 
in recent years have revealed that it carries out many key endocrine functions. Indeed, 
dysfunction of the adipose compartment is central to the pathology associated with 
metabolic diseases such as obesity, type 2 diabetes, cancer cachexia and 
lipodystrophies58. 
There are two main types of adipose tissue in mammals, white adipose tissue 
(WAT) and brown adipose tissue (BAT). Adipocytes from WAT are optimized to store 
energy and are characterized by containing a large single cytoplasmic lipid droplet and a 
“squeezed” nucleus. BAT adipocytes dissipate energy for thermogenesis and are 
characterized by being polygonal cells with a roundish nucleus and several cytoplasmic 
lipid droplets. Thus, white and brown adipocytes are quite different in their morphology 
and physiology: white adipocytes store energy for the metabolic needs of the organism, 
whereas brown adipocytes burn energy for thermogenesis59. WAT is the main type of 
adipose tissue found in adult humans and is distributed throughout the body in 
subcutaneous regions, surrounding visceral organs and in the face. It is an active 
endocrine organ that mostly regulates insulin sensitivity, lipid metabolism and satiety58. 
During caloric excess periods, adipocytes readily convert glucose into FAs storing 
them along with those collected from the extracellular space. During periods of caloric 
deficit, stored triacylglycerols are hydrolysed to FFAs and glycerol60, which then leave the 
cell towards other tissues.  
 
Obesity is characterized by excess body fat, which is predominantly stored in the 
adipose tissue leading to adipose cells expansion. As adipose cells expand, more 
phospholipids have to be incorporated into cellular membranes. The specific mechanisms 
that may lead from obesity towards the higher risk of metabolic complications such as 
insulin resistance and type 2 diabetes remain elusive. One hypothesis is the adipose tissue 
expandability that states that adipose tissue has a limited maximal capacity to increase in 
mass. When the adipose tissue expansion limit is reached, it stops storing lipids 
appropriately. The excess lipid accumulates in organs such as muscle, liver, and pancreas, 
causing metabolic disease with insulin resistance61. 
While the idea that lean and very obese people may develop insulin resistance 
through the same pathogenic paradigm of exhaustion of adipose tissue expandability is 
controversial61, it is actually well supported in rodent models; for example, studies in 
mouse have demonstrated that even in overweight or obese mice, a genetic limit on 
adipose tissue expansion can exacerbate insulin resistance62,63. In humans, lipidomic 
analyses of adipose tissue of lean and obese (but metabolically healthy) individuals, 
identified multiple changes in membrane phospholipids. Using computer modeling, it was 
shown that “lean” and “obese” membrane lipid compositions have the same physical 
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properties despite their different compositions64. These changes in lipid membrane 
composition were suggested to occur in order to protect the physical properties of the 
membranes. 
The expandability limit is determined on an individual basis by environmental and 
genetic factors61. Since dietary FAs may incorporate into the membranes and/or serve as 
precursors to other FAs they may also have a role in the expansion capacity of adipocyte 
cell membranes. 
 
 
5. Genetic background and animal models. 
 
It is well accepted that the genotype influences the metabolism of nutrients in 
particular lipid metabolism. How the membrane biophysical properties are affected by 
the genetic background and regulated to match the specific needs of the individual is still 
obscure. 
Considering problems in collecting tissue samples and the multifactorial etiology 
of obesity in human patients, suitable animal models are essential for a better 
understanding of the metabolic onset of obesity. Pigs display several anatomical-
physiological and metabolic similarities to humans65. Additionally, taking advantage of 
pigs genetic background (fat or lean, genetic or diet induced obesity), pigs are considered 
a valuable animal model. Zucker rats are also commonly used as a genetic model for 
human obesity66. The fa/fa Zucker rat is a strain of laboratory animal descendent from 
the wild model rodent Rattus norvegicus67, used often to study genetic obesity problems. 
This animal model develops morbid obesity, through the fa/fa mutation in the 
extracellular domain of the leptin receptor, which inhibits completely leptin action. This 
leads to an appetite increase promoting severe insulin resistance68. The rat is a highly 
valuable model for the investigation of cardiovascular diseases, metabolic disorders (e.g. 
lipid metabolism, diabetes), cancers, renal dysfunctions, neurologic pathologies, and so 
many other diseases. 
In addition, in these studies we also used bovines that are models for animal 
production studies. This approach allows investigating the possible correlation of dietary 
fats with membrane features and possible outcome on meat quality. 
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Aim of part I: 
The work presented in part I - chapter 1 of this thesis includes publications 1, 2 
and 3 that are focused on the study of the influence of genetic background and diet on 
adipocyte membrane composition and its outcome on membrane biophysical properties 
such as fluidity and permeability to water and glycerol. 
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CHAPTER 1 - Influence of diet on cell membrane composition and 
biophysical properties  
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CHAPTER 1 - Influence of diet on cell membrane composition and 
biophysical properties  
 
 
The information contained in this chapter is included in the following original publications: 
 
 
Publication1 
 
Martins AP, Lopes PA, Martins SV, Madeira A, Santos NC, Prates JA, Moura TF, Soveral G. 
Conjugated linoleic acid reduces permeability and fluidity of adipose plasma membranes from 
obese Zucker rats. 
Biochem Biophys Res Commun. 2010 Jul 23;398(2):199-204. 
doi: 10.1016/j.bbrc.2010.06.059. 
 
 
 
Publication 2 
 
Martins AP, Lopes PA, Costa AS, Martins SV, Santos NC, Prates JA, Moura TF, Soveral G. 
Differential mesenteric fat deposition in bovines fed on silage or concentrate is independent of 
glycerol membrane permeability. 
Animal. 2011 Dec;5(12):1949-56. 
doi: 10.1017/S1751731111001091. 
 
 
 
Publication 3 
 
Martins AP, Lopes PA, Madeira MS, Martins SV, Santos NC, Moura TF, Prates JA, Soveral G. 
Differences in lipid deposition and adipose membrane biophysical properties from lean and obese 
pigs under dietary protein restriction. 
Biochem Biophys Res Commun. 2012 Jun 22;423(1):170-5. 
doi: 10.1016/j.bbrc.2012.05.108. 
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Publication 1: Conjugated linoleic acid reduces permeability and fluidity of adipose plasma membranes from obese Zucker rats. 
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Publication 2: Differential mesenteric fat deposition in bovines fed on silage or concentrate is independent of glycerol membrane permeability. 
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Publication 3: Differences in lipid deposition and adipose membrane biophysical properties from lean and obese pigs under dietary protein restriction. 
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INTRODUCTION 
 
 
One of the fundamental tasks of the plasma membrane is to quickly respond to 
intra and extracellular events. Water is the major component of living organisms, thus 
controlled flow of water into and out of cells is central for cell homeostasis. Although 
water can cross biological membranes through the lipid bilayer, membrane water 
permeability can be greatly enhanced by specific proteins called aquaporins (AQPs). 
These transmembrane proteins enable the fine-tuning of water permeation and in some 
cases also small solutes. Part II of this thesis will focus on different aspects of these 
proteins. 
 
 
Aquaporins 
 
AQPs are a family of small transmembrane channels ubiquitous in nature. These 
proteins form highly selective channels that, in response to osmotic or solute gradients, 
facilitate bidirectional flow of water and in the case of aquaglyceroporins, other small 
solutes such as glycerol and urea, enabling the adjustment of these flows to the organism 
necessities. 
 
The existence of water channels was predicted long before aquaporin discovery. 
The first studies on water transport started in the late 1950s on mammalian red blood 
cells (RBC)69–72 and later on renal epithelia73 and demonstrated that water permeability 
in these cells was much higher than predicted by simple water diffusion through the 
bilayer. Evidence for their existence was based mainly on measures of high osmotic water 
permeability, on their inhibition by mercurial reagents69,70, on the low activation energy 
for transport74 and finally on the ratio of osmotic to diffusion water permeabilities75 
leading to the proposed single-file mechanism of transport within the channel76. In 1984 
it was identified a major intrinsic protein in bovine lens cells that was suggested to 
participate in the formation of an aqueous channel77. But only in the 1990s, using a 
Xenopus oocyte expression assay, Agre and co-workers78 demonstrated that a 28-kDa 
membrane protein that is abundant in RBC and renal proximal tubules 79 was water 
permeable. The 28-kDa membrane protein was later named aquaporin-1 (AQP1). 
Ever since their discovery, more than 300 homologues from many phyla, including 
bacteria, plant, and animal have been identified80. In prokaryotic and other 
microorganisms, AQPs are believed to aid survival by providing protection against 
osmotic shocks and rapid freezing81,82. In Escherichia coli there are two MIP family 
proteins: one is the glycerol facilitator (GlpF)83 and the other is the water channel 
(AQPZ)84. More AQP genes are present in the genomes of multicellular organisms: 
Arabidopsis thaliana contains 35 putative AQP genes85 while in humans, 13 AQPs 
isoforms, distributed in specific organs, tissues and with different cellular localization 
have been identified so far3. The identification and study of mammalian AQPs have 
provided insight at the molecular level into the fundamental physiology of water balance, 
regulation and the pathophysiology of water balance disorders3,86. 
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Furthermore, aside from water and glycerol, numerous studies have pointed out 
a broader range of AQPs’ substrates, these include polyols, hydrogen peroxide, ammonia, 
nitrate, arsenite, antimonite, small ions, and gases87. 
 
The widespread distribution of this ancient family of channels in all kingdoms of 
life points to their fundamental significance in biology.  
 
 
1. Aquaporin classification and selectivity. 
 
Thirteen mammalian AQPs, have been described so far. These can be divided in 
three sub-groups mainly determined by their transport capabilities: i) orthodox or 
classical AQPs (AQP0, AQP1, AQP2, AQP4, AQP5, AQP6 and AQP8), primarily water 
selective facilitating water movement across cell membranes in response to osmotic or 
pressure gradients and, ii) aquaglyceroporins (AQP3, AQP7, AQP9 and AQP10) which 
transport some small uncharged solutes such as glycerol and urea in addition to water. A 
third sub-group, named iii) S-aquaporins (AQP11 and AQP12), was defined based 
primarily on their subcellular location and on the lower sequence similarity to the other 
mammalian AQPs (Figure 5). 
 
 
 
Figure 5 - Phylogenetic tree of the human Aquaporin gene family (Adapted from 88). Water permeable AQPs 
(AQP0, 1, 2, 4, 5, 6, 8, AqpZ) are shown in blue background. Glycerol permeable aquaglyceroporins (AQP3, 
7, 9, 10, GlpF) are in orange background. AqpZ and GlpF are the E. coli homologues. S-Aquaporins (AQP11 
and 12) is on the bottom right with green background. The scale bar represents genetic distance between 
homologues. 
Numerous studies have revealed the diverse permeation characteristics of AQPs. 
In addition to water and glycerol, a diverse set of solutes including small ions, urea, 
hydrogen peroxide, ammonia, nitrate, arsenite, antimonite and gases87, has been shown 
to permeate through specific AQPs. Aquaglyceroporins AQP3, AQP7, AQP9 and AQP10 
transport glycerol and urea89–92 , while both AQP7 and AQP9 are permeable for arsenite93. 
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In addition, AQP9 also permeates a wide range of non-charged solutes like mannitol, 
sorbitol, purines and pyrimidines94. AQP6 has low water permeability and seems to 
function primarily as an anion transporter95,96. In addition, AQPs have also been proposed 
to transport gases, including carbon dioxide, ammonia, nitric oxide and hydrogen 
peroxide97–99. However, some of these permeability characteristics are still controversial 
and subject of intense debate100,101. 
 
 
2. Aquaporin structure. 
 
The three dimensional structures of several AQPs has enabled the 
conceptualization of a general structure, revealing the structural determinants that are 
essential for AQPs selectivity and extraordinary permeation rates. The atomic model of 
mammalian AQP1 derived from a 3.8 Å resolution potential map obtained by electron 
crystallography was the first atomic structure of a human membrane protein to be solved, 
and gave the first insight into AQP’s water specificity102. Medium and high-resolution 
structures of several AQPs belonging to different subfamilies have been ever since 
determined, namely, from archaea103, bacteria104,105, yeast106, protozoa107, plants108 and 
mammals109–112. More recently, molecular dynamics (MD) simulations have 
complemented the experimental data, by providing the progression of the biomolecular 
system at atomic resolution101. 
The reported structures have revealed that AQPs are grouped as homotetramers 
embedded in the bilayer113, consisting of four independent monomers, each behaving as 
an independent channel114 (Figure 6) and sharing a conserved overall typical hourglass 
fold102,115. 
 
 
Figure 6 - Tetrameric structure of bovine AQP1. (A) side view, (B) top and bottom views. Reprinted with author's 
permission116. 
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Each monomer interact with two of its neighbours, forming the tetramer central 
pore. It has been suggested that this pore, which is not involved in water conductance102, 
may permeate gases99,117,118 and function as a gated cation channel119,120. Each AQP 
monomer is a small protein with usually fewer than 300 amino acids, organized in six 
transmembrane α-helices (H1-6) arranged in a right-handed helical bundle and 
connected by five loops (A-E), with both amino and carboxyl termini located in the 
cytoplasm side121,122 (Figure 7A). The angle at which the transmembrane α-helices are 
oriented gives rise to funnel-shaped cytoplasmic and extracellular vestibules connected 
by the conduction pore. The latter is formed by two small α-helical segments, loop B, 
entering from exoplasmatic side and connecting H2 and H3, while loop E enters from the 
cytoplasmatic side and connects H5 and H6, called HB and HE respectively123. 
 
 
 
Figure 7 - Monomeric structure of bovine AQP1. (A) side view, (B) top and bottom views. The red mesh 
indicates the pore region. Reprinted with author's permission116. 
 
Aquaporins have important characteristics (two filters) that provide selectivity for 
water and some small solutes, preventing protons and solutes above a certain size and 
charged solutes to permeate (Figure 8). The amino acid residues of the first selective filter 
is for most AQPs composed of two highly conserved asparagine-proline-alanine (NPA), 
called signature motifs, located at the end of the loops (HB and HE). These motifs are 
oriented 180 degrees toward each other, forming part of the surface of the aqueous 
pathway at the centre of the pore. The chemical/structural characteristics of this region, 
mostly due to the presence of these residues and the dipole behaviour of the two half 
63 
 
helices HB, generates an electric field124 that induces upon the interaction with the 
asparagines, a rotation of the water molecule, thus disrupting any H-bonds between 
adjacent water molecules and preventing the Grottus mechanism for protons 
permeation102,104,109,115,125,126,127. The second important selective filter located at the 
extracellular side, the aromatic/arginine (ar/R) constriction region, prevents permeation 
of solutes above 2.8 Å and of charged solutes109. Within this region a hydrophobic 
phenylalanine residue side chain (Phe 58 in bAQP1) orients the water molecules such as 
to enforce strong hydrogen bonds to an arginine and a histidine (Arg 197 and His 182 in 
bAQP1) (Figure 8A). Besides these selective filters in the pore, the channel has in the 
vestibules at the entrance of either side, in the vestibules, different residues, mainly 
carbonyl groups that interact with water molecules82,109. Furthermore, the wall regions 
of the pore have different hydrophobic/hydrophilic characteristics determining, 
conduction rate and the open/closed state of the channel82. 
 
 
 
Figure 8 - Detailed view of bovine AQP1 pore region. (A) Half helices dipoles and the hydrophilic and 
hydrophobic residues lining the pore are depicted in red and yellow, respectively; the ar/R and NPA 
selective filters are shown as well; (B) Inside view of the pore surface (hydrophilic and hydrophobic 
properties are painted red and yellow, respectively). Reprinted with author's permission116. 
 
In the highly dielectric (ε = 80) bulk water, protons are well solvated by 
surrounding water molecules. Upon moving the proton across the AQP pore, the 
solvation shell needs to be removed from the proton thus creating an electrostatic 
barrier128,129. Inside the pore, the hydronium ion is only partially solvated by few close 
water molecules, and the surrounding protein medium (ε ≈ 4) stabilizes the hydronium 
only to a fraction of the solvation in the bulk. Thus, a large energetic cost results for 
moving the hydronium from the water into the pore. Inside the pore, water molecules 
move in single file, so whenever and wherever bulk water-water hydrogen bonds have to 
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be ruptured to allow the water molecule to squeeze through the narrow NPA or ar/R 
regions (so preventing protons to permeate AQPs), the protein offers replacement 
interactions, which largely compensate for the energetic cost of water-water bond 
rupture. This remarkable complementarity to bulk water lowers the activation barrier to 
a large extent. Furthermore, the high permeation rates are observed both experimentally 
and in simulations101,109. The high permeation rate is thought to be partially due to the 
hydrophobic nature of some pore regions, where water molecules have to pass rapidly, 
while they slowdown in hydrophilic regions upon interactions with residues. The 
conduction rate is so, modulated by the hydrophobicity/hydrophilic characteristics of the 
pore and is often referred as saltatory conduction (named after the saltatory ion 
conduction in axons).  
 
 
 
3. Aquaglyceroporin structure. 
 
The structure of Escherichia coli glycerol facilitator GlpF revealed that the AQP 
general fold topology is conserved among orthodox AQPs and aquaglyceroporins104,130. 
Yet GlpF permeability to water is substantially less than that measured for its bacterial 
AQP counterpart AqpZ83,131. 
The ar/R constriction region of GlpF has Trp48, Gly191, Phe200, and Arg205109 
instead of Phe56, His180, Cys189 and Arg195 in AQP1. Among the water-specific AQPs, 
the histidine residue, which is preserved among water-specific AQPs, together with the 
highly conserved arginine residue providing a hydrophilic edge in juxtaposition to an 
aromatic residue123. On the other hand, for GlpF, the replacement of this histidine by 
glycine significantly increases the size of this constriction region and sterically allows a 
second residue change, replacing the cysteine by a phenylalanine109,123,132. These 
substitutions have two critical effects on the characteristics of the GlpF ar/R constriction 
region: they increase its size, making it wider than AQP1 (3.4Å and 2.8Å, respectively) and 
also increase its hydrophobicity109. It seems that the more hydrophobic nature of GlpF is 
the primary factor responsible for its relatively reduced ability to transport water109,133. 
Moreover, the ladder of aromatic residues (Phe and Trp) in GlpF constriction region forms 
a greasy slide that allows the efficient conduction of glycerol, small linear polyols, and 
urea, while making it less efficient for water passage123. 
The GlpF channel lining is strongly amphipathic, with oxygens and nitrogens lined 
up on one side and carbons on the opposite side of the lumen surface. This amphipathic 
channel uniquely matches the chemical structure of glycerol, which is a composite of the 
polar hydroxyl group arranged on a non-polar alkyl backbone104. The glycerol permeation 
through the selectivity filter of GlpF depends on the orientation of the glycerol molecule 
inside the pore. In the narrow ar/R selectivity filter of the channel all three hydroxyl 
groups of glycerol are able to form hydrogen bonds to polar protein groups or to the 
nearby water molecules134. Two consecutive OH groups of the glycerol molecule are 
oriented with ideal geometry with respect to donor and acceptor atoms from within the 
channel104. 
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4.  Aquaporin regulation. 
 
One important aspect regarding AQPs is that they are tightly regulated. Eukaryotic 
AQPs are frequently regulated post-translationally either by gating, which controls of the 
channels’ rate of flux, or by trafficking, whereby AQPs are shuttled from intracellular 
storage sites to the plasma membrane135. Within the gating mechanisms, it is well 
established that eukaryotic AQPs are often directly regulated by pH, phosphorylation, 
divalent cations136 and membrane tension137,138,139. These regulatory mechanisms 
directly affect the protein conformation, which in turn impacts its transport capacity. 
AQPs pore structure dictates both the permeation rate and the channel specificity 
and so, changes in its structure resulting from changes in pH or from other external 
factors will affect water and solute fluxes140. Since the specificity of the pore is high, only 
small changes of a few or even a single residue are required to produce the gating 
phenomenon. Small changes of critical residues at the pore entrances may obstruct the 
pore as well123. For some AQPs, the mechanism of the conformational transition from a 
closed state to an open one has already been elucidated140. High-resolution structures of 
gated AQPs show that the cytoplasmic entry contains another very narrow constriction 
site, which significantly hinders the movement of water molecules135. Three eukaryotic 
AQP structures solved at high-resolution reveal the presence of this second constriction 
site: mammalian AQP0 found in the eye lens110,111,141, SoPIP2;1 a plant plasma membrane 
AQP108, and Aqy1 a yeast plasma membrane AQP106. From these structural results, two 
distinct pictures of ‘capping’ and ‘pinching’ have emerged to describe how 
transmembrane water channels are gated140. From this perspective SoPIP2;1 and Aqy1 
are ‘‘cappers” that dramatically reduce their water transport activity through gating135. 
Both loop D in SoPIP2;1 and the N-terminus in Aqy1 cap the channel within the 
cytoplasmic side, leading to the repositioning of a key residue that ends up blocking the 
movement of water135. In this context AQP0 represents a special case since its 
cytoplasmic entrance appears to be always blocked by Tyr149; yet this channels’ activity 
seems to be further adjusted by small conformational changes that ‘‘pinch” on either 
constriction region of the pore135. 
 
 
 
5. Physiological relevance. 
 
Mammalian AQPs are widely expressed in the body. They are differently 
distributed in several organs and tissues involved in fluid transport, such as epithelia (the 
wall of tubular organs), as well as in other tissues that do not have an obvious role in fluid 
transport, such as adipocytes3. For example: kidneys express eight AQPs isoforms (AQP1, 
2, 3, 4, 6, 7, 8 and 11) along the water-permeable segments, of which five have been 
shown to play a role in body water balance (AQP1, 2, 3, 4 and 7)142; in brain cells of 
rodents and primates, eight isoforms have been described (AQP1, 3, 4, 5, 6, 8, 9 and 12) 
from which AQP4 is the most abundant143. Additionally, one type of cell may have more 
than one isoform, for example RBC express the orthodox AQP1 and the aquaglyceroporin 
AQP3. 
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The AQP channels are involved in numerous physiological processes as well as in 
several pathological conditions, such as: Transepithelial fluid transport in the kidney 
where several regions of tubules and microvessels must own a high water permeability 
necessary to achieve its urine-concentrating function142. Epithelial fluid secretion (eg. 
saliva secretion in salivary glands and insulin and pancreatic fluid secretion in 
pancreas)144. Cell migration where AQPs are necessary to enhance formation of 
membrane protrusion at the leading end of a migrating cell, which is critical for cell 
motility thus facilitating wound healing processes145 as well as tumour cell infiltration and 
metastasis146. Brain water transport where water permeation across the blood–brain 
barrier and the blood–cerebrospinal fluid barrier facilitates the movement of water into 
and out of the brain3. Most brain diseases (e.g. stroke, traumatic brain injury, brain 
tumors, brain inflammation) present the hallmark of oedema, that consists in water 
accumulation resulting from brain osmotic homeostasis dysfunctions143. Neuroexcitation, 
where AQP4-facilitated water transport in astrocytes during potassium reuptake 
following neuroexcitation causes contraction of the extracellular space, maintaining the 
driving force for potassium reuptake3. Skin hydration, AQP3 expressed in epidermal cells 
facilitates skin hydration by maintaining high glycerol levels in the stratum corneum, 
which acts as a humectant to retain water147,148. Cell proliferation where AQP3 expressed 
in epidermal cells enhances the proliferation rate of basal keratinocytes149 by  
maintaining high cellular glycerol levels necessary for ATP formation and lipid 
biosynthesis, leading to cellular proliferation3. Another example is AQP5 that might 
interact in signalling pathways switching on other proteins that ultimately turn on genes 
involved in cell growth in colon cancer150 and lung cancer151. These interactions may 
represent novel AQP functions, which are unrelated to water or solutes transport146. 
Glycerol metabolism, where the interplay between two AQPs, AQP7 expressed in 
adipocytes (that enables the efflux of glycerol, thus preventing intracellular accumulation 
of glycerol and triglycerides involved in the pathophysiology of diabetes) and AQP9 
expressed in liver (which facilitate the uptake of glycerol and thereby the availability of 
glycerol for de novo synthesis of glucose and triglyceride), have an important role in 
controlling glycerol metabolism in both adipose tissue and liver152. 
 
The physiological relevance of AQPs is well documented by studies of the 
phenotypes of AQP-knockout mice that have provided most of the information on AQP 
physiology as well as by the discovery of humans with non-functioning mutations3,153 or 
altered AQP distribution and expression in pathological situations154. These and other 
studies point to a broad potential for AQP based therapies. 
 
 
 
5.1. AQP3 as drug target. 
 
AQPs are involved in several pathological conditions, and since their discovery 
they have been increasingly singled out as important drug targets useful in the treatment 
of several pathologies. Depending on the AQP isoform, location, function, and on the 
particular pathological condition several therapeutic approaches have been proposed by 
many authors3,154,155. In this work, the AQP3 potential role for therapy will be addressed. 
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AQP3 is normally expressed in renal collecting duct epithelial cells. Together with 
AQP4, it is constitutively active as water channel on the basolateral membrane while, on 
apical membrane, water transport is mediated by a vasopressin-induced trafficking of 
AQP2 from an intracellular compartment142. AQP3 levels of expression are regulated on 
a long term basis, where prolonged water deprivation increases AQP3 protein and mRNA 
levels156 which was mainly attributed to the increased vasopressin levels observed157. 
Additionally, phenotypes of AQP-null mice revealed defects in urine-concentrating 
function158. Hence inhibition of these AQPs would produce an aquaretic response similar 
to that produced by vasopressin V2 receptor antagonists3. 
AQP3 is also expressed in the basal layer of proliferating epidermal keratinocytes. 
AQP3-deficient mice exhibited impaired skin hydration148, reduced skin elasticity, delayed 
wound healing recovery147. Thus AQP3 activators are expected to enhance skin hydration, 
elasticity and wound healing mechanisms. However there is also an established link 
between AQP3 expression in the epidermis and skin cancer. AQP3 is known to be 
overexpressed in skin tumours159. In addition, AQP3-null mice showed to be remarkably 
resistant to the development of skin tumours probably due to impaired glycerol uptake 
by tumour cells160. This association between AQP3 expression levels and skin cancer 
appeals for caution in the use of activators of AQP3 activity161. Due to AQP3 involvement 
in skin tumour cell proliferation and probably also cell migration, an AQP3 inhibitor would 
have a therapeutical role in this type of cancer both as anti-proliferative and anti-
metastatic agent. 
AQP3 is also present in the conjunctiva and corneal epithelium of rat, dog, and 
mouse162–165. The transepithelial water flow in the corneal endothelium is mainly 
paracellular and less transcellular, thus the role of AQPs in cell membranes is to allow the 
fast cellular osmotic equilibration, which is necessary to maintain optimal rates of fluid 
movement166. Also, as seen in many cell types, AQPs in the cornea are found to be 
involved in cell migration and proliferation. In mouse, AQP3 deficiency was associated 
with impaired wound healing (reduced corneal re-epithelialization and delayed 
restoration of full-thickness epithelia after scraping) what was related to a defect in cell 
migration and cell proliferation arising from AQP3 deletion164. Thus it was suggested that 
AQP3 induction might provide a possible therapy to accelerate the resurfacing of corneal 
defects. In corneal endothelial diseases such as pseudophakic bullous keratopathy (BK), 
whose clinical hallmark is the chronic corneal oedema, it was reported an altered 
expression of AQPs including increased AQP3165. AQP changes in BK corneas suggest 
future BK therapies including treatments that can suppress AQP3 expression or function 
in order to control cornea oedema. 
AQP1, 4, 3 and 5 are expressed in lacrimal glands165,167. AQP3 is located on the 
basolateral membranes of acinar cells. However, knockout mice lacking AQP3 (and also 
AQP1, 4 and 5) showed unaltered tear secretion167. This finding does not support an 
essential role for AQPs in lacrimal gland fluid secretion. It was proposed that the 
requirement for AQPs in salivary but not lacrimal gland secretion, may involve the 
substantially slower fluid secretion rate across lacrimal gland acinar cells. However, 
another study showed that in patients with Sjögren's syndrome (an autoimmune disorder 
characterized by decreased lacrimal and salivary gland secretions, resulting in severe dry 
eye and dry mouth), AQP5 is localized in the cytoplasm and not in its normal location, the 
apical membranes168. This defect in lacrimal gland AQP5 trafficking was related to 
decreased lacrimation and dry eye in these patients, thus supporting AQPs essential role 
68 
 
in fluid secretion rate across lacrimal glands of humans. Clearly, additional work is needed 
for a better understanding of AQPs function in the lacrimal gland in order to understand 
the therapeutic potential of AQPs in this cells. 
AQP3 is also expressed in Immune cells. T cells were reported to expressed AQP3. 
Based on AQP3-deficient mice phenotypes, it was proposed to regulate T cells trafficking 
in cutaneous immune reactions where, T cell migration toward chemokines would be 
dependent on AQP3-mediated hydrogen peroxide uptake and not on the water/glycerol 
transport169. The authors proposed that AQP3 should be considered a target for T cell–
mediated diseases. For example, inflammatory skin diseases, such as atopic dermatitis 
and psoriasis, are characterized by the infiltration of T cells into both the dermis and the 
epidermis of affected skin170. Thus, impairing AQP3 function would be useful in the 
treatment of inflammatory skin diseases. 
AQP3 is expressed in resident peritoneal macrophages’ plasma membrane171. 
AQP3-deficient mice showed significantly greater mortality than wild-type mice in a 
model of bacterial peritonitis, linking AQP3 as a novel determinant in macrophage 
immune function by a cellular mechanism involving water and glycerol transport, and 
consequent phagocytic and migration activity171. This AQP3 involvement in key 
macrophage function suggested AQP3 as a novel therapeutic target in modulating the 
immune response in various infectious and inflammatory conditions. 
AQP3 is expressed at the Intestinal epithelium in the basolateral membrane of 
colonic epithelial cells. However little is known regarding the details of the physiological 
role of AQP3 in gastrointestinal tract172. AQP3 null mice developed severe colitis with 
colonic haemorrhage, marked epithelial cell loss and death173. The results suggested a 
novel role for AQP3 in enterocyte proliferation that is probably related to its glycerol-
transporting function. AQP3 is thus a potential target for therapy of intestinal diseases 
associated with enterocyte destruction, such as Crohn’s disease, that are associated with 
enterocyte hyper- or hypoproliferation173. 
AQP3 is also expressed in red blood cells174. On the other hand, the life-cycle of 
some parasites such as Plasmodium falciparum (the infectious agent of malaria a 
devastating worldwide disease) outlines additional opportunities for pharmacological 
intervention in the treatment of human pathologies. Host AQPs are also potential drug 
targets in some parasitosis. For example, the malarial parasite, dwelling within 
erythrocytes, relies on human-AQP3 or mouse-AQP9 in the erythrocyte membrane to 
obtain glycerol175. 
Finally, tumour generally overexpress AQPs including isoforms that are normally 
found in their cell of origin as well as others not originally present.  AQPs role in cancer 
may be related to tissue water balance, cell migration, cell proliferation and cell 
adhesion146 leading to tumour angiogenesis, invasion, metastasis and growth3. AQP3 
have been reported to be over expressed in a wide range of carcinomas (e.g. liver 
cancer176, oesophageal cancer177, pituitary adenomas, salivary gland tumours, thymic 
tumours, adenocarcinoma of the lung and prostate, squamous cell carcinomas of the 
skin, oesophagus and uterine cervix, apocrine carcinoma of the breast, germinal cell 
tumours of the ovary and testis and urothelial carcinoma of the bladder159, collecting duct 
carcinoma178, among others). Still there is much to know about the mechanisms 
underlying AQPs relevance in tumours physiology. AQP3, however, is considered as 
having a great potential as a drug target in cancer therapy and thus AQP3 inhibitors will 
certainly be of broad utility. 
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Additionally to drug targeting, since the levels of AQPs expression are altered in 
many pathological conditions, AQPs detection are now being considered as biomarkers 
for diagnosis.  
 
 
 
5.2. Aquaporin modulators. 
 
The current knowledge about AQP pathophysiology outlines great potential in 
treatments targeting AQP function. AQPs based modulator drugs are predicted to be of 
broad utility in the treatment of several disorders, such as cerebral oedema, cancer, 
obesity, wound healing, epilepsy, glaucoma and malaria3,154. 
Search for AQP based therapies has become a thriving topic. AQPs are now the 
focus of pharmaceutical sciences. However, finding inhibitors suitable for use in humans 
has turned out to be unexpectedly challenging and elusive.  
 
The inhibition of water permeation in RBCs (which express AQP1) by sulfhydryl-
reactive heavy metal ions and organomercurial compounds, such as pCMBS (p-
chloromercuribenzene sulphonate), has been known since the 70s179. Later on the  thiol 
group of Cys189 residue of the loop E was identified as the biding site responsible for 
HgCl2 inhibition114. The mercury (II) sterically occlude the water pore through a covalent 
bond with Cys189 residue that projects inside the pore while other AQPs (such as AQP4) 
that lack a cysteine residue at this position are resistant to inhibition by mercurial 
compounds180. However, recent molecular dynamic studies have suggested that mercury 
disrupts the water pore of AQP1 through local conformational changes in the ar/R 
region181. Other heavy metals such as Gold (HAuCl4)182, Silver (AgNO3 and silver-
sulphadiazine)182, Nickel (NiCl2), Copper (CuCl2) and Zinc (ZnCl2)183 have also been shown 
to inhibit water and/or glycerol permeability in different AQPs. 
Small molecules, not containing metals have also been reported to inhibit water 
permeation. One example is the non-selective ion channel blocker tetra-ethylammonium 
(TEA+), a blocker of voltage-gated potassium channels, calcium-dependent potassium 
channels and the nicotinic acetylcholine receptor. TEA+ was reported to inhibit AQP1, 
AQP2 and AQP4184,185. However, this effect was not corroborated by other studies, which 
indicated little or no AQP inhibition by TEA at concentrations up to 10mM186,187. 
In general, all the compounds mentioned so far are valuable for gaining insight 
into the effect of AQP modulation on a cellular level, but they are not suitable for 
therapeutic applications due to their toxic side effects and lack of selectivity. 
The diuretic carbonic anhydrase inhibitor, acetazolamide188–190 and other related 
sulfonamides191 as well as several anti-epileptic drugs192 were reported as efficient 
reversible blockers of AQP1 and AQP4. However, these effects were not confirmed by 
other studies186,187,193. and the utility of these antiepileptic drugs as AQP inhibitors has 
been questioned, since they are known to interact with multiple relevant targets194. 
Recently, the loop diuretic bumetanide as well as a synthesized analogue 
(AqB013) and furosemide were reported to inhibit water fluxes of both human AQP1 and 
rat AQP4194,195, while an analogue of furosemide (AqF026) was reported to slightly 
increase AQP1 activity196. 
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AQP4–IgG (immunoglobulin G) autoantibodies in NMO were found to impair 
water transport in AQP4 expressing X. laevis oocytes197, although other studies reported 
that AQP4–IgG autoantibodies does not inhibit AQP4 water permeability198,199.  
More recently, organic small-molecule compounds have been described as 
modulators of orthodox AQPs154. TGN-020 (2-nicotinamido-1,3,4-thiadiazole), an AQP4 
inhibitor200, was also shown to reduce cerebral oedema in rodent models201, a radio-
labeled version of which has been developed to study AQP distribution in vivo using 
positron emission tomography (PET)202. In addition, a recent report identified some 
compounds containing carboxylic groups and an aromatic moiety, acting as inhibitors of 
human AQP1203. In another study, as a result of a screening assay, four molecules were 
identified as effective inhibitors of mediated water transport of both AQP1 and AQP4204, 
but the mechanism by which they interact with the water channels is still unknown. 
Concerning aquaglyceroporin’s activity regulation by organic modulators, up to 
date, not much is known. Phloretin was found to be effective in inhibiting AQP994, but it 
has been also reported to inhibit solute transporters, as well as ion channels, and thus 
exerts profound effects on osmotic gradients in multiple ways205. More recently some 
small-molecule inhibitors of mice AQP9 glycerol permeability have been reported206, but 
given their poor water solubility, these compounds are not yet suitable for in vivo 
experimentation. 
 
 
 
6. Plant aquaporins. 
 
Comparatively with other organisms, plants have a remarkable large number of 
AQPs homologues, ubiquitously expressed. Genome sequencing revealed the presence 
of 35 MIP-encoding genes in Arabidopsis, 36 in maize and 33 in rice207. 
Based on their sub-cellular localization and sequence similarity, plant AQPs are 
classified into seven subfamilies: PIPs (plasma membrane intrinsic proteins), TIPs 
(tonoplast intrinsic proteins), NIPs (nodulin26-like intrinsic proteins), SIPs (small basic 
intrinsic proteins), XIPs (x intrinsic proteins), HIPs (hybrid intrinsic proteins) and GIPs 
(GlpF-like intrinsic proteins)208–211.  
Besides water, plants AQPs are reported to transport a broad range of subtracts 
including other small molecules and/or gases of physiological relevance in plant 
development and adaptation under stress conditions212,213,211. 
The wide range of substrates for these proteins as well as their complex regulation 
levels and pathways together with some emerging aspects of their functionalities207, 
make them behave more like multifunctional, highly adapted channels rather than simple 
water and solute pores. 
Plant growth and development are dependent on the tight regulation of water 
uptake and transport across cellular membranes and tissues214. Therefore, it is crucial 
that plant AQPs are subjected to a fine-tuned regulation according to cell/tissue type, 
environmental conditions as well as plant developmental stages. Besides regulation of 
gene expression, the activity of AQPs protein is regulated by various posttranslational 
modifications such as methylation, glycosylation, phosphorylation, membrane trafficking, 
heteromerization. Their gating can also be regulated by pH, divalent ions and membrane 
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tension215,137. Various stress conditions like anoxia, salt and water stress have also been 
reported to affect the activity of aquaporins in plants213,215. 
 
 
 
7. Aquaporin heterologous expression in yeast  
 
The yeast Saccharomyces cerevisiae constitutes a valuable system for numerous 
studies on the basic cellular and molecular mechanisms, processes that are well 
conserved between yeast and higher eukaryotes, including mammals. Due to the 
functional similarity to higher eukaryotes, the ease of genetic manipulation and the 
existence of a collection of yeast gene deletion strains, the yeast model has been 
considered an attractive organism to study AQP physiology and to screen for compounds 
of potential pharmacological use216. AQP from several organisms including mammals and 
plants has been successfully expressed in yeast, allowing channel analysis either using 
whole yeast cells217 or vesicles containing the expressed AQP218. 
 
 
 
8. Functional studies to assess aquaporin activity. 
 
Water/solute transport assays have been performed using isolated cells from 
different organisms, such as bacteria219, yeast220,221, and animal cells222. Intracellular 
vesicles223 as well as plasma membrane vesicles obtained from animal tissues (mainly 
kidney or intestinal epithelia) were used to evaluate AQP functionality either in 
intracellular organelles224 or in transepithelial water fluxes225. Other widely used 
approach consists in aquaporin heterologous expression in Xenopus laevis oocytes, which 
have very low intrinsic water permeability, to functionally characterize novel AQP 
isoforms78. In addition to oocytes, yeast cells lacking endogenous AQPs have also been 
used as a system for heterologous expression217. 
Cell volume changes induced by osmotic gradients are used to study membrane 
permeability allowing the evaluation of the osmotic water permeability (Pf) and/or solute 
permeability (Ps) coefficients, the activation energy of water and/or solute transport (Ea). 
High Pf and/or Ps and low Ea values indicate the existence of functional water and/or 
solute channels while low permeabilities and high Ea indicates permeation occurs mostly 
through lipids. Pf is the proportionality constant between the measured volume change 
and the pressure gradient applied (osmotic and/or hydrostatic) and can be attained by 
following the time course of cell volume change (dV/dt) during an osmotic shock with an 
impermeant solute. Ps is the proportionality constant between the measured volume 
change and the solute gradient applied and can also be attained by following dV/dt, 
during the application of a permeant solute gradient. If the osmotic shock is applied with 
a permeant solute, fluxes of water and solute occur simultaneously, but at different rates, 
and both movements are responsible for volume changes and must be taken into account 
when evaluating both permeabilities. These measurements can be obtained using 
volume dependent physical parameters based in optical properties such as light 
transmission or absorbance, light scattering and fluorescence of volume sensitive dyes. 
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A commonly used method to follow rapid volume changes is the stopped flow 
spectroscopy. In the stopped flow device, cell/vesicles suspensions are subjected to 
osmotic challenges by rapid mixing with an equal volume of hypo or hyperosmotic 
solution. For vesicle or cell suspensions, light of a chosen wavelength is directed to the 
observation chamber through an optical fiber and the change in 90º light scattered is 
followed until a stable signal is attained. An alternative approach uses cell/vesicles loaded 
with fluorescent dyes and the changes in fluorescence intensity of the suspension are 
monitored by stopped-flow fluorescence. Signals are calibrated into volumes and used 
for permeability evaluation. 
Stopped-flow experiments can be done in plasma membrane vesicles from AQP-
expressing cells, in reconstituted proteoliposomes or in small cells such as erythrocytes. 
For larger cells, kinetics of cell volume change due to osmotic gradients is followed by 
microscopy. This is the case of Xenopus oocytes expressing AQPs (by cRNA injection) 
where swelling kinetics is determined by image analysis of oocyte cross-sectional area205. 
In another configuration, cells are grown as monolayer cultures, loaded with a 
fluorescent dye, mounted on the stage of an epifluorescence microscope and subjected 
to osmotic challenges by extracellular addition osmotic solutions. Fluorescence signals 
resulting from cell volume changes together with cell image analysis are used to evaluate 
kinetics of cell volume changes and Pf and/or PS. 
Regulation of AQP function by pH, phosphorylation or specific inhibitors, can be 
screened through simple measurements of Pf and/or PS and Ea. However, AQP gating by 
physical parameters such as membrane surface tension implies the design of specific 
protocols that can only be applied to vesicle systems139,226 or walled cells220 that can 
sustain membrane tensions without rupture. 
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Aim of part II 
 
Part II aims at screening for AQPs modulators with potential utility for drug 
development. Chapter 2 encloses two publications (publications 4 and 5) where human 
erythrocytes were used as a cell model to screen the inhibitory effect of gold coordinated 
compounds, accessing their effects in human AQP1 (an orthodox AQP) and human AQP3 
(an aquaglyceroporin).  
Chapter 3 encloses 2 publications (publications 6 and 7), where S. cerevisiae was 
used as a heterologous expression system for studying the activity of individual plant 
AQPs. Plant cells express numerous AQPs isoforms whose function is still unclear; the 
development of a cell model where they can be individually characterized is crucial for 
functional assays. Yeast cells deleted in their endogenous AQPs thus having low intrinsic 
water permeability, were used to express and functionally assess grapevine AQPs. 
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CHAPTER 2 – Aquaporins as Drug Targets 
 
 
The information contained in this chapter is included in the following original publications: 
 
 
Publication 4 
 
Martins AP, Marrone A, Ciancetta A, Galán Cobo A, Echevarría M, Moura TF, Re N, Casini A, 
Soveral G 
Targeting aquaporin function: potent inhibition of aquaglyceroporin-3 by a gold-based compound. 
PLoS One. 2012;7(5):e37435. 
doi: 10.1371/journal.pone.0037435. 
 
 
 
Publication 5 
 
Martins AP, Ciancetta A, de Almeida A, Marrone A, Re N, Soveral G, Casini A. 
Aquaporin inhibition by gold(III) compounds: new insights. 
ChemMedChem. 2013 Jul;8(7):1086-92. 
doi: 10.1002/cmdc.201300107. 
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Publication 4: Targeting aquaporin function: potent inhibition of aquaglyceroporin-3 by a gold-based compound. 
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Publication 5: Aquaporin inhibition by gold(III) compounds: new insights. 
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CHAPTER 3 - Aquaporin Functional Assessment in the Yeast Cell Model 
 
 
The information contained in this chapter is included in the following original 
publications: 
 
 
Publication 6 
 
Sabir F, Leandro MJ, Martins AP, Loureiro-Dias MC, Moura TF, Soveral G, Prista C. 
Exploring three PIPs and three TIPs of grapevine for transport of water and atypical 
substrates through heterologous expression in aqy-null yeast. 
PLoS One. 2014 Aug 11;9(8):e102087. 
doi: 10.1371/journal.pone.0102087. 
 
 
 
Publication 7 
 
Noronha H, Agasse A, Martins AP, Berny MC, Gomes D, Zarrouk O, Thiebaud P, Delrot S, 
Soveral G, Chaumont F, Gerós H. 
The grape aquaporin VvSIP1 transports water across the ER membrane. 
J Exp Bot. 2014 Mar;65(4):981-93. 
doi: 10.1093/jxb/ert448. 
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Publication 6: Exploring three PIPs and three TIPs of grapevine for transport of water and atypical substrates through heterologous 
expression in aqy-null yeast. 
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Publication 7: The grape aquaporin VvSIP1 transports water across the ER membrane. 
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GENERAL DISCUSSION AND CONCLUSIONS 
 
 
The work presented in this thesis encompasses different aspects of biological 
membranes features. Membranes are barriers that assure the selective communication 
of the internal media with the external environment; membrane components, lipids and 
proteins, are key players responsible its selective permeability and regulation. 
 
 
Part I of this thesis is dedicated to the study of the influence of dietary conditions 
in membrane biophysical properties, namely fluidity and permeability. In collaboration 
with the Veterinary School of Lisbon University, we used animal models and designed 
experiments where the effects of dietary FAs (PUFA and CLA) and reduced protein diets 
(RPD) on membrane composition, fluidity and permeability were analysed. In addition, 
since the animal genetic background is known to have an important contribution for the 
regulation of several biochemical pathways resulting in different phenotypes, this 
variable was included in the study. 
 
One aspect of these experiments is the observation that, despite the significant 
changes in dietary components, we can only observe relatively small variations on FAs 
membrane composition. This probably reflects that, besides the complex set of processes 
that FAs face after ingestion (e.g. digestion, absorption, transport, metabolizing and 
finally incorporation into membranes), regulatory mechanisms accurately control 
membrane composition ensuring optimized cellular function30. 
 
In this work we studied CLA effects in obese Zucker rats fed a hyperlipidic (high 
fat) and atherogenic (high cholesterol) diet, a trial aiming to mimic an obese human sub-
population with severe metabolic problems that consumes CLA supplements (publication 
1). We observed that the FA composition of adipose membranes of Zucker rats is highly 
dependent on diet's lipid composition. It must be noted that animals were fed with fat 
from different origins - palm oil (rich in saturated fats) or ovine fat (rich in unsaturated 
fats) and that additionally, diets were supplemented with CLA. It was found that the lipid 
deposition on membranes was highly dependent on the specific dietary fat and in 
particular, CLA was found incorporated into adipose membranes reflecting relative 
patterns of CLA intake.  Furthermore, in palm oil group the total sum of n-3 FA was highly 
dependent on the fat origin. This was correlated to the fact that compared with ovine fat, 
palm oil has less alpha-linolenic acid227, an essential omega-3 FA, precursor of these n-3 
PUFA classes that cannot be synthetized de novo. Thus, in the case of Zucker rats, the 
type of dietary lipids clearly influenced the lipid membrane composition. 
Regarding the membrane biophysical properties, we were able to correlate a 
decrease in membrane fluidity and the concomitant decrease on permeability to water 
and glycerol with the specific incorporation of t10,c12 CLA isomer into adipose 
membranes of Zucker rats. Interestingly, this same isomer has been suggested to have 
fat lowering properties in several animal studies228. 
 
In publication 2, bovines were fed with silage (similar to natural feeding) or 
concentrate. In ruminants the FAs metabolization profile is completely different from 
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other species. In this specie unsaturated FAs undergo an extensive biohydrogenation in 
the rumen, with consequently high levels of SFA being absorbed in the intestine and 
deposited in the tissues229. As consequence, dietary lipids do not directly affect the FA 
composition of ruminant adipose tissues, as they do in non-ruminants230. In this case, 
neither breed nor diet affected fluidity and permeability of adipose plasma membranes. 
 
Under reduced protein diet conditions, lower contents of linoleic (18:2n-6) and 
arachidonic acids (20:4n-6) were detected in pigs (publication 3), with a subsequent lower 
PUFA sum, in particular from the n-6 family. This results from the fact that dietary linoleic 
acid is the precursor for the synthesis of arachidonic acid, thus predicting a proportional 
variation in the content of both FAs. 
The genetic background in obese pigs was found to play a determinant role on the 
fluidity of adipose membranes by increasing membrane fluidity (publication 3) in 
accordance with the reported for a wide variety of other cell membranes from obese 
mice and rats. 
 
To correlate the outcome of different dietary conditions on membrane 
composition and biophysical properties from different biological systems can be an 
intimidating puzzle. By one side, membrane lipid composition tends to be conserved, one 
the other hand, several biological conditionings may contribute for adaptive responses, 
which may have several consequences, including altered membrane lipid composition. 
Relatively small changes in the concentration of membrane lipids, in the order of 10%, 
are significant enough to alter biophysical properties of the membrane231. Thus we can 
speculate that even minor concentrations of some FA, may affect lipid packing within 
cellular membranes thus contributing to alterations in membrane fluidity and 
permeability. Additionally, Biological membranes are extremely complex. Thousands of 
different lipids interacts with each other, where phospholipids, cholesterol and other 
membrane components are not only organized in several different domains but also 
distributed in an asymmetric pattern in both sheets of the bilayer. Certainly, this 
heterogeneity implies also heterogeneity in the biophysical properties of the membrane. 
Although these aspects were not taken into account, our results enabled to correlate 
dietary components with membrane lipid composition and with membrane biophysical 
properties, namely fluidity and permeability. As discussed above in the context of 
membrane composition (general introduction of part I), these findings likely reflect 
membrane adaptation pointing to compensatory mechanisms that maintain membrane 
biophysical properties preserving optimal cellular function. 
 
One consideration goes to the animal models used in this study. Rodent is a model 
wildly used in biomedical research. In particular, obese Zucker rats used in this study are 
models for investigation of human obesity. The pig is also emerging rapidly as a 
biomedical model for studying energy metabolism and obesity in humans.  This results 
from the fact that pigs are devoid of postnatal brown fat, have similar cardiovascular 
system and proportional organ sizes and metabolic features65. Additionally, porcine is 
also a model for animal production studies. Bovines are solely models for animal 
production, moreover they have a different digestive metabolism where FA undergoes 
an extensive biohydrogenation in the rumen229; despite not being comparable with the 
previous species, investigation of dietary effects on membrane composition and adipose 
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tissue features can contribute to the improvement of ruminant feeding with possible 
outcomes in meat quality. 
 
An interesting observation is that, within the same animal species all adipose 
membranes were found richer in SFA independently of their genetic background or diet. 
The distribution pattern of the main FAs follows the trend SFA > MUFA > PUFA. These 
results suggest a consistent FA pattern in the adipocyte membrane of the different 
species tested, coherent with a conservation of the lipid bilayer structure adapted to the 
specialized functions of these cells. The general pattern observed is in contradiction with 
the current idea that membranes are richer in PUFAs than in SFA. 
 
 
 
 
 
 
Part II of this thesis is devoted to the study of membrane protein channels, AQPs, 
aiming at identifying new modulators with potential pharmacological use. Additionally, 
building an experimental cell model able to characterize individual AQP activity and 
selectivity, as well as to validate modulators effect and potency, was another goal of this 
work. 
 
AQPs are important membrane proteins that control fluxes of water, glycerol and 
other small solutes through biological membranes. They are now recognized as important 
players in several physiological and pathological processes. Taking into account their 
broad distribution in the body and the extensive spectrum of pathologies where AQPs 
are involved, they are predicted to be of broad utility in the treatment of several diseases 
both as therapeutic targets and diagnostic agents. However, only a small number of AQP 
inhibitors suitable for clinical trials has been described so far. With this in mind, and taking 
into account that AQPs activity is inhibited by some metal salts, we decided to explore 
the properties of coordination metal complexes as possible inhibitors. 
 
Using human RBCs that express one orthodox aquaporin (AQP1) and one 
aquaglyceroporin (AQP3) as a screening system we reported on the potent and selective 
inhibition of AQP3 by a water-soluble Au(III) coordination compound, Auphen 
(publication 4). The selectivity towards AQP3 was confirmed using transfected PC12 cell 
lines with overexpression of either AQP1 or AQP3. Based on the recovery of AQP3 activity 
after mercaptoethanol addition and knowing that Au(III) has affinity for sulfhydryl groups, 
we proposed a mechanistic hypotheses where AQP3 inhibition would occur through 
direct biding of Cys residues to the gold centre of the metal compounds. Thus Auphen 
inhibitory mechanism was investigated using molecular modelling studies together with 
analysis of non-covalent binding of Auphen to AQP1 and AQP3 by docking approaches. 
Since no human glycerol channel has a resolved structure yet, we built a homology model 
of human AQP3 using the crystal structure of E. coli’s glycerol facilitator (GlpF) as 
reference. This approach allowed us to propose Cys40 as the likeliest candidate for 
binding to gold(III) complexes via a direct Au-thiol bond. In AQP3, the thiol group of Cys40 
is projected towards the extracellular space approaching the channel pore. Contrariwise, 
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in AQP1 none of the cysteine, methionine or histidine residues present in the extracellular 
surface appear to be accessible for gold binding (residues with sulphur-donor groups, 
with which gold(III) ions are prone to interact). 
Indeed, these results were later confirmed by our group using site directed 
mutagenesis in which Cys40 was replaced by a serine residue (Ser40)232, confirming our 
initial proposal that for Auphen mechanism of action. 
 
The potent and selective inhibitory effect of Auphen prompted us to further 
investigate other gold-based compounds as possible AQP3 inhibitors (publication 5). We 
selected a series of square planar Au(III) complexes containing functionalised bipyridine 
or terpyridine ligands. Moreover, to compare the effects of metal substitution on the 
AQP3 inhibition potency, phenantroline derivatives of Pt(II) and Cu(II) were also used. The 
effects of these compounds on both water and glycerol permeation were also tested on 
human RBCs. Au(III) was shown to be the most effective inhibitor of glycerol permeability, 
comparable in potency to Auphen. 
 
Given the diversity of pathologies associated with dysfunction of the different 
AQPs, these proteins are now emergent drug targets. AQP-based modulator drugs are 
predicted to be of broad potential utility in the treatment of several diseases including 
cancer and others, as well as diagnostic agents. The identification of selective inhibitors 
for different AQP isoforms is a first step towards this avenue. One important question to 
be addressed is the effect of these compounds on other AQP isoforms. Additionally, a 
better understanding of AQP regulation and gating would allow its manipulation 
facilitating the identification of new putative modulators. However, it should be noted 
that cells and tissues frequently express more than one AQP isoform in the plasma 
membrane and, unless a specific isoform is mutated or overexpressed, its function is not 
easily discriminated. To this end we needed to develop a heterologous system for 
expression and functional assessment of AQP isoforms. 
Such a cell system expressing individual AQPs would also be very useful for 
analysis of function and regulation of AQPs from the plant kingdom. Plant performance 
is highly dependent on the tight regulation of water permeation across cellular 
membranes and tissues. An important role for plant AQPs, more than to promote paths 
for water movements, is to provide regulation of water flow triggered by environmental 
modifications, an essential funtion under stress conditions. Plants express numerous AQP 
isoforms, but for most their physiological relevance is still unclear. 
Heterologous expression in yeast is considered an excellent model for the study 
of proteins in general, because there is a large library of available strains and their genetic 
manipulation is easy and inexpensive when compared with cultures of animal cells. S. 
cerevisiae is an appropriate heterologous expression system for AQPs due to the intrinsic 
low water permeability of the yeast plasma membrane. Moreover, contrary to animal 
cells, yeast cells can survive in severe external environments allowing establishing 
experimental conditions where AQP selectivity and gating can be evaluated.  
Thus, we used a strain of S. cerevisiae silenced in endogenous AQPs for the 
expression and functional characterization of pant AQPs (publication 6). The grapevine 
Vitis vinifera is a plant usually withstanding hostile drought conditions essential for the 
quality of berries and wine. Using GFP as a gene reporter, V. vinifera PIPs and TIPs AQP 
expression and localization in the yeast plasma membranes was confirmed by 
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fluorescence microscopy. Subsequently, yeast were functionally analysed using a 
methodology previously developed by our group220 that uses intact yeast cells in their 
native physiological status to evaluate water and glycerol transport. 
Using this approach, we showed that three AQPs from V. vinifera (VvTnPIP2;1, 
VvTnTIP1;1 and VvTnTIP2;2) are functional for water transport, while other three 
(VvTnPIP1;4, VvTnPIP2;3 and VvTnTIP4;1) are non-functional, and that functional AQPs 
were found to be sensitive to HgCl2, a well-known but unselective inhibitor of AQP 
activity. Our results also indicate that V. vinifera AQPs are putative transporters of other 
small molecules of physiological importance (publication 6). Their sequence analyses 
revealed the presence of signature sequences for transport of ammonia, boron, CO2, 
hydrogen peroxide and urea. 
To clarify the function of VvSIP1, an intracellular AQP localized in the ER, ER 
membrane vesicles expressing VvSIP1 were isolated and purified from yeast cells and 
water transport activity was monitored. In parallel, proteoliposomes containing purified 
VvSIP1 were also tested for AQP activity. Both ER vesicles and proteoliposomes displayed 
higher water transport activity and lower activation energy for water transport, 
confirming that VvSIP1 is able to facilitate water diffusion. Importantly, this is also the 
first experimental evidence that VvSIP1 is able to transport water but not glycerol, urea, 
sorbitol, glucose, or inositol (publication 7). 
One longer-term goal of our research is to identify human AQP inhibitors. The 
results obtained herein validate the yeast cell model as a useful and simple heterologous 
expression system to characterize the activity of individual AQPs. In addition, this cell 
model can be used to screen for compounds with pharmacological potential as well as to 
study gating mechanisms and pH regulation of AQP permeation. 
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FUTURE PRESPECTIVES 
 
 
During the work developed and herein presented, many ideas arose that could bring 
new insights into the field of membrane properties modulation by dietary components. 
The techniques optimized are now available to assess particular aspects of membrane 
composition. Moreover, other biochemical tools could be used to analyse membrane 
lipid composition in more detail (e.g., phospholipid content) giving valuable information 
to interpret changes in membrane biophysical properties. 
 
The results obtained in this work regarding gold compounds as inhibitors of 
aquaglyceroporins unveiled numerous other issues to be addressed, such as their effect 
on other human AQPs as well as more insights to their modulation mechanisms. To assist 
these questions, we have now a yeast cell model as a valuable tool to investigate 
individual AQP modulation. In this way, the effect of the compounds described in this 
thesis as AQP3 inhibitors can be investigated on other human AQPs as well as in other 
from diverse origin. For example, non-mammalian AQPs from pathogenic organisms 
responsible for human diseases (bacteria, fungi, parasites) could be investigated using 
the yeast cell model. In particular, parasite AQPs are involved in crucial functions for 
parasite physiology, suggesting that they can be targets for human parasitosis 
therapeutics. 
 
This model will also enable to screen for new modulators as well as to study AQP 
regulation mechanisms including pH regulation and gating. Additionally, it would allow 
site directed mutagenesis in order to study inhibition and regulatory mechanism. 
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